These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13935130)

  • 1. Enzymatic cyclization of L-glutamine and L-glutaminyl peptides.
    MESSER M
    Nature; 1963 Mar; 197():1299. PubMed ID: 13935130
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphate ions and glutaminyl cyclases catalyze the cyclization of glutaminyl residues by facilitating synchronized proton transfers.
    Seifert F; Demuth HU; Weichler T; Ludwig HH; Tittmann K; Schilling S
    Bioorg Chem; 2015 Jun; 60():98-101. PubMed ID: 25981125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminyl cyclases display significant catalytic proficiency for glutamyl substrates.
    Seifert F; Schulz K; Koch B; Manhart S; Demuth HU; Schilling S
    Biochemistry; 2009 Dec; 48(50):11831-3. PubMed ID: 19921850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A spectrophotometric assay for glutaminyl-peptide cyclizing enzymes.
    Bateman RC
    J Neurosci Methods; 1989 Oct; 30(1):23-8. PubMed ID: 2811431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative folding and N-terminal cyclization of onconase.
    Welker E; Hathaway L; Xu G; Narayan M; Pradeep L; Shin HC; Scheraga HA
    Biochemistry; 2007 May; 46(18):5485-93. PubMed ID: 17439243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method to convert N-terminal glutamine to pyroglutamate for characterization of recombinant monoclonal antibodies.
    Xu W; Peng Y; Wang F; Paporello B; Richardson D; Liu H
    Anal Biochem; 2013 May; 436(1):10-2. PubMed ID: 23357233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclization of N-terminal glutamine and carbamidomethyl-cysteine (residues) on the chromatographic behavior of peptides in reversed-phase chromatography.
    Reimer J; Shamshurin D; Harder M; Yamchuk A; Spicer V; Krokhin OV
    J Chromatogr A; 2011 Aug; 1218(31):5101-7. PubMed ID: 21665210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells.
    Cynis H; Schilling S; Bodnár M; Hoffmann T; Heiser U; Saido TC; Demuth HU
    Biochim Biophys Acta; 2006 Oct; 1764(10):1618-25. PubMed ID: 17005457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On peptides. XIII. L-tyrosyl-L-leucyl-L-valine].
    ZAHN H; MESSERKNECHT HE
    Hoppe Seylers Z Physiol Chem; 1959 Aug; 315():228-31. PubMed ID: 13846785
    [No Abstract]   [Full Text] [Related]  

  • 10. Substrate specificity of glutaminyl cyclases from plants and animals.
    Schilling S; Manhart S; Hoffmann T; Ludwig HH; Wasternack C; Demuth HU
    Biol Chem; 2003 Dec; 384(12):1583-92. PubMed ID: 14719800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of fish and microbial transglutaminases on glutaminyl sites of peptides derived from threadfin bream myosin.
    Hemung BO; Li-Chan EC; Yongsawatdigul J
    J Agric Food Chem; 2008 Aug; 56(16):7510-6. PubMed ID: 18671401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides.
    Fischer WH; Spiess J
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3628-32. PubMed ID: 3473473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
    Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymes as reagents in peptide synthesis: enzymatic removal of amine protecting groups.
    Meyers C; Glass JD
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2193-6. PubMed ID: 1056024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice.
    Katsara M; Deraos G; Tselios T; Matsoukas J; Apostolopoulos V
    J Med Chem; 2008 Jul; 51(13):3971-8. PubMed ID: 18563891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressure/temperature combined treatments of precursors yield hormone-like peptides with pyroglutamate at the N terminus.
    Fernández García A; Butz P; Trierweiler B; Zöller H; Stärke J; Pfaff E; Tauscher B
    J Agric Food Chem; 2003 Dec; 51(27):8093-7. PubMed ID: 14690402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of disease activity in multiple sclerosis. Studies of myelin basic protein-like materials.
    Whitaker JN
    Ann N Y Acad Sci; 1984; 436():140-50. PubMed ID: 6085224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous spectrometric assays for glutaminyl cyclase activity.
    Schilling S; Hoffmann T; Wermann M; Heiser U; Wasternack C; Demuth HU
    Anal Biochem; 2002 Apr; 303(1):49-56. PubMed ID: 11906150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-ultraviolet circular dichroism spectroscopy of sequential peptides 1-63, 64-95, 96-128, and 129-168 derived from myelin basic protein of rabbit.
    Martenson RE; Park JY; Stone AL
    Biochemistry; 1985 Dec; 24(26):7689-95. PubMed ID: 2418871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant production of isotope-labeled peptides and spontaneous cyclization of amino-terminal glutamine into pyroglutamic acid.
    Mischo A; Ohlenschläger O; Gührs KH; Görlach M
    Chembiochem; 2012 Jul; 13(10):1421-3. PubMed ID: 22619187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.